Deep Sound Wave Therapy for the prevention of neuropathy in the treatment of colorectal and breast cancer with chemotherapy: a pilot / feasibility study '

Withdrawn

• Conditions: neuropathische aandoening; neuropathy; neurotoxicity; 10027656

• Registration Number: NL-OMON46640
• Lead Sponsor: Isala Klinieken

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 15 April 2024

Recruitment & Eligibility

• Status: Withdrawn
• Sex: Not specified
• Target Recruitment: 40

Inclusion Criteria

subjects who will start adjuvant chemotherapy in the form of CapOx or Paclitaxel.
subjects in the age of >18 year

Exclusion Criteria

subjects with a pacemaker
subjects with a weight greater than 140 kg.
subjects previously treated with neurotoxic medication
Patients with active rheumatoid arthritis.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>In order to assess whether neuropathy has developed after the last<br /><br>chemotherapy, the primary endpoint was chosen 3 months after the last<br /><br>treatment. The number of fully / dosed courses, prevention of neuropathy<br /><br>(measured according to current guidelines in the department and measured with<br /><br>the FACT / GOG-NTX-13 questionnaire), use of medication against neuropathy and<br /><br>the experience of patients with DSWT (questionnaire Numerical Rating Scales /<br /><br>open questions are registered</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>nvt</p><br>